Esma S. B.
- Country
- France
- Department
- Medical Oncology
Research Overview
- Evaluation of Anti-GD2 Antibody-Drug Conjugate M3554 in Patients with Advanced Solid Tumors
- A Phase 2 Study of Olaparib Monotherapy in Participants with Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer
- Phase 1b/2 Study of Oral LRK-4189 Monotherapy and LRK-4189 Combination Therapy with Standard Chemotherapy in Metastatic Colorectal Cancer and Solid Tumors
Data & Insights
Has run more than one trial at 156 of 301 partner sites.
Specializations
Sarcoma Research
Specialized focus on treating oligometastatic sarcomas through innovative therapeutic combinations, particularly exploring the integration of immunomodulation with high-dose radiation therapy.
- Stereotactic Body Radiation Therapy (SBRT)
- Immunotherapy Applications
- Soft Tissue Sarcoma Management
Active investigation in progression-free survival outcomes for sarcoma patients.
Head and Neck Cancer
Dedicated research in advanced treatments for head and neck squamous cell carcinoma, with particular emphasis on innovative immunotherapy combinations for recurrent and metastatic cases.
- Novel Immunotherapy Approaches
- Combination Therapy Strategies
- First-line Treatment Development
Focus on enhancing treatment efficacy through targeted immunotherapeutic interventions.
Precision Oncology
Expertise in treating solid tumors with specific genetic alterations, particularly focusing on FGFR gene mutations and their targeted therapeutic approaches.
- FGFR-targeted Therapies
- Molecular Tumor Profiling
- Recurrent Cancer Treatment
Specialized in evaluating tumor response to targeted molecular therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.